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1088-132 Enteral Nutrition Affects Body Composition, Plasma 
Lipids and Cytokines in Cardiac Cachexia: Interim 
Analysis of a Double-Blind, Placebo-Controlled 
Intervention Trial
Rozentryt Piotr, Michalak Alicja, Szewczyk Marta, Chwist-Nowak Aleksandra, Nowak 
Jolanta, Polo_ski Lech, Zembala Marian, Anker D. Stefan, Silesian Center of Heart 
Diseases, Zabrze, Poland, National Heart and Lung Institute, London, United Kingdom
Background. Plasma lipids are suggested as modulators of inflammation. Enteral nutri-
tion (EN) of patients with cardiac cachexia (CC) may change plasma lipids and therefore
alter inflammation.
Methods. We assessed the effects of EN on plasma lipids, body fat content by DEXA,
and cytokines (all in pg/mL). 29 pts with CC (all weight loss>7,5%, 4 female, BM=21,7±2
kg/m2, NYHA 2,7±0,5, LVEF 24±9%) were randomized 3:1 to EN of 600 kcal/day (added
between main meals) (ingredients per 600 kcal: proteins–20g, carbohydrates–72g, fat–
26g) or placebo (clouding agent: 12 kcal/day). 3 pts died: 1–sudden cardiac death, 2- due
to pump failure, 1 was transplanted. Remaining 19 patients (15 M, 4 F, age: 49±15y)
were receiving nutrition, 6 patients placebo. Before nutrition (v1), directly after its with-
drawal, that is 6 weeks after baseline (v2) and 12 weeks thereafter (v3), we performed
DEXA, assessed plasma lipids, cytokines and quality of life by Minnesota score.
Results. Responses noticed in patients receiving EN are shown in the table (paired t-
test, NS=p>0.1).
Conclusions. In patients with CC, EN increased body weight, which was mainly fat
mass. This response was associated with opposite changes of plasma lipids that
increased, and inflammatory cytokines that decreased.
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1089-109 Correlation Between Angiotensin II Receptor Subtype 1 
and Vitronectin Receptor in Cardiac Transplantation
Mohamad H. Yamani, Randall C. Starling, E. Murat Tuzcu, Daniel Cook, Philip Paul, 
Norman B. Ratliff, Yang Yu, Robert Hobbs, Gustavo Rincon, Corinne Bott-Silverman, 
Patrick M. McCarthy, James B. Young, Cleveland Clinic Foundation, Cleveland, OH
Background: Experimental evidence suggests that angiotensin II up-regulates the vit-
ronectin receptor (αVβ3).We have recently shown that recipients of hearts from donors
with spontaneous intracerebral hemorrhage (ICH) are at increased risk of allograft vascu-
lopathy compared to trauma donors. We have also shown that allograft vasculopathy is
associated with up-regulation of αVβ3.
Objectives: This study was undertaken to evaluate the correlation between angiotensin
II receptor subtype 1 (AT1R) and αVβ3 in heart transplant recipients.
Methods: We evaluated mRNA expressions of AT1R and αVβ3 (Real-time PCR, Taq-
Man) in donor spleen lymphocytes (prior to transplantation) and endomyocardial biopsies
(one-week post-transplant) in 20 recipients from ICH donors and 20 recipients from
trauma donors. All patients underwent coronary intravascular ultrasound at baseline and
one-year of transplant to evaluate for transplant vasculopathy.
Results: Baseline characteristics were similar except for increased donor age in the ICH
group. At one week of transplant, heart biopsies from ICH group showed significant
increased expression of αVβ3 (3.8 x fold, P = 0.012) and AT1R (4.7 x fold, P= 0.001)
compared to Trauma group. Further, the ICH group showed significant increased mRNA
expression of αVβ3 (3.5 x fold, P= 0.014) and AT1R (2.6x fold, P=0.004) in the donor
spleen lymphocytes suggesting the presence of systemic activation of both AT1R and
αVβ3 prior to transplantation. At one year, the ICH group showed accelerated progres-
sion of coronary vasculopathy measured as change in coronary intimal thickness (CMIT:
0.69± 0.37 vs 0.39±0.35 mm; P= 0.01), and change in plaque volume (CPV: 6.3± 2.6 vs
4.1±2.5 mm3; P= 0.02) compared to Trauma group. Using multivariate regression analy-
sis both, AT1R and αVβ3 in the donor spleen lymphocytes were independently associ-
ated with coronary vasculopathy. A significant correlation was also noted between AT1R
and αVβ3 (r=0.37, P=0.014) in the donor spleen lymphocytes.
Conclusions: Donor spontaneous intracerebral hemorrhage is associated with systemic
activation of both AT1R and αVβ3. Such an interaction may play a key role in the patho-
genesis of allograft vasculopathy.
1089-110 Mean Annual Change in Duration of QTc Correlates to 
10-Year Survival Following Orthotopic Heart 
Transplantation
Robert E. Eckart, Mark W. Kolasa, Michael D. Kwan, Karl C. Stajduhar, Mark E. Peele, 
Brooke Army Medical Center, Fort Sam Houston, TX
Background: Serial QT interval measurements over time may quantify the degree of
myocardial repolarization heterogeneity. Currently the most routinely used noninvasive
method to assess ventricular recovery time is the QT interval measurement made from
the 12-lead electrocardiogram (ECG). Heterogeneity of recovery time has been sug-
gested to increase the risk of fatal arrhythmias. We sought to examine the correlation
between 10-year survival and ventricular repolarization heterogeneity in the patient with
orthotopic heart transplant (OHT).
Methods: Electrocardiographic records of patients having undergone OHT more than 10
years prior were reviewed. Each patient had their QTc interval charted as a function of
time since undergoing OHT. The slope of each patient’s QTc as a function of time was
then calculated. The slope was then qualified as a change of greater than, or less than
10msec per year.
Results: Thirty-six patients underwent OHT more than 10 years prior. The mean survival
of the cohort was 9.8±5.7 years. The patients had 766 ECGs available for comparison.
When assessing for interventricular conduction delay, there was no clinically significant
difference in mean QRS duration between those surviving beyond 10 years versus those
that died within 10 years (94.0±15.4 vs. 87.6±12.3 msec, p<0.01). The mean QTc change
per year in those surviving versus dying prior to 10 years was 5.5±13.6 vs 20.2±23.8
msec (p=0.024). The survival at 10 years for those with a mean annual QTc change of
less than 10 msec versus greater than 10 msec was 72% versus 14%, respectively
(p=0.008).
Conclusions: Ventricular repolarization heterogeneity, as assessed by serial QTc mea-
surements over time, identifies those patients at increased risk for 10-year mortality fol-
lowing OHT.
1089-111 The Renal Benefit of Calcineurin Inhibitor-Free 
Immunosuppression After Heart Transplantation: Is It 
Safe?
Jon A. Kobashigawa, Jignesh K. Patel, Angela Marquez, Brandy T. Oeser, Jaime D. 
Moriguchi, Hillel Laks, University of California, Los Angeles, CA
Background: The nephrotoxicity of calcineurin inhibitors (CIs) can lead to hemodialysis in
certain patients after heart transplantation. Various strategies have been devised to
reduce the nephrotoxic effects of CIs. Most recently, successful withdrawal of CIs with
immunosuppression consisting of mycophenolate mofetil and sirolimus have been
reported. However, there still remains concern regarding subsequent rejection risk and
the renal benefit of this protocol. Methods: Between 11/02 and 5/03, seven heart trans-
plant patients with serum creatinines > 2.8 mg/dl were entered into our renal sparing pro-
tocol. All patients were on either cyclosporine (6) or tacrolimus (1) along with
mycophenolate + prednisone. For our protocol, sirolimus was added to their regimen at 1
mg/day and titrated to attain a level between 4-8 ng/ml while the current CI dose was
halved. Mycophenolate levels were maintained between 2-5 mcg/ml. When sirolimus lev-
els became therapeutic (usually within 2-4 weeks), the CI was discontinued with endomy-
ocardial biopsy being performed 4 weeks later. Results: 6 of 7 patients had successful
decrease in serum creatinine at two months after discontinuation of CI. One patient (on
cyclosporine) necessitated hemodialysis. The mean serum creatinine of the 6 patients
prior to discontinuation of CI was 3.7 + 0.7 mg/dl (range 2.8 - 4.6 mg/dl) which decreased
to a mean of 2.7 + 0.3 mg/dl (range 2.3 - 3.2 mg/dl), p=0.02. At 4 weeks after discontinu-
ation of CI all echocardiograms were normal and at 6 weeks all endomyocardial biopsies
were negative for rejection (ISHLT grade 0). Conclusion: Renal sparing immunosuppres-
sion with weaning of calcineurin inhibitor and maintenance with mycophenolate and
sirolimus appears safe and effective in heart transplant patients experiencing renal fail-
ure.
1089-112 Acute Rejections During Late Posttransplant Periods in 
Pediatric Heart Transplant Recipients
Michael Dandel, Dagmar Kemper, Lehmkuhl Hans, Martin Bettmann, Rudolf Meyer, 
Onnen Grauhan, Christoph Knosalla, Manfred Hummel, Roland Hetzer, Deutsches 
Herzzentrum Berlin, Berlin, Germany
Previously we showed that acute rejection (AR) surveillance by intramyocardial electro-
gram (IMEG) recordings in children make routine biopsies unncessary and reduce the
mortality linked to ARs. Due to the low incidence of late ARs and their usually harmless
course, IMEG recordings were ended at 2 years after heart transplantation (HTx). How-
ever, the impact of late ARs on the long-term outcome is controversial, especially in chil-
dren. Therefore, we reviewed the late ARs in our patients to evaluate their clinical
relevance.
Methods: All children whith post-HTx time >2 years, who were transplanted between
1986-1999, were reviewed for prevalence and severity of late ARs diagnosed after seces-
sion of IMEG monitoring. Attention was also focused on temporal relationships between
late ARs and the new appearance or aggravation of coronary artery vasculopathy (CAV).
Results: Of the 68 reviewed patients (age 8.3± 5.4 years at HTx), 22 (32.4%) showed 1-
5 clinically relevant late ARs, which occurred for the first time at 5.0± 3.0 years post-HTx.
Of all reviewed patients, 15 (22.1%) died during the study period at 6.7± 3.0 years after
HTx. Of these deaths, 7 (46.7%) occurred during AR, 3 (20 %) were sudden deaths
shortly (2-6 weeks) after AR treatment, 2 (13.3%) were related to severe CAV and 1
Results in nutrition group
Parameter v1 v2 v3. 1vs2 1vs3
Weight [kg] 63.4±10 65.4±10 66.0±11 .00003 .001
Minnesota 47 ± 24 37 ± 24 42 ± 24 .008 .057
Fat–legs [kg] 4.3±1.0 4.8±1.2 5.1±1.1 .005 .004
Fat–trunk [kg] 7.9±2.8 9.0±2.4 9.3±2.4 .01 .01
Fat–total [kg] 15.2±3.4 16.6±3.9 17.2±4.2 .002 .02
TotChol [mmol/L] 5.1±0.9 5.3±1.1 5.7±1.4 NS .03
LDLCH [mmol/L] 3.0±0.9 3.3±1.1 3.6±1.2 NS .01
TNFα [pg/ml] 12.7±17 6.1±9 2.4±3.4 NS .02
TNFα SR I [pg/ml] 2.4±2.7 2.4±1.9 1.1±0.9 NS .063
TNFα SR II [pg/ml] 5.1±3.5 5.0±4.0 3.2±3.7 NS .02
